Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement
- PMID: 18838716
- DOI: 10.7326/0003-4819-149-9-200811040-00243
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement
Abstract
Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for colorectal cancer.
Methods: To update its recommendation, the USPSTF commissioned 2 studies: 1) a targeted systematic evidence review on 4 selected questions relating to test characteristics and benefits and harms of screening technologies, and 2) a decision analytic modeling analysis using population modeling techniques to compare the expected health outcomes and resource requirements of available screening modalities when used in a programmatic way over time.
Recommendations: The USPSTF recommends screening for colorectal cancer using fecal occult blood testing, sigmoidoscopy, or colonoscopy in adults, beginning at age 50 years and continuing until age 75 years. The risks and benefits of these screening methods vary. (A recommendation). The USPSTF recommends against routine screening for colorectal cancer in adults 76 to 85 years of age. There may be considerations that support colorectal cancer screening in an individual patient. (C recommendation). The USPSTF recommends against screening for colorectal cancer in adults older than age 85 years. (D recommendation). The USPSTF concludes that the evidence is insufficient to assess the benefits and harms of computed tomographic colonography and fecal DNA testing as screening modalities for colorectal cancer. (I statement).
Comment in
-
Screening guidelines for colorectal cancer: a twice-told tale.Ann Intern Med. 2008 Nov 4;149(9):680-2. doi: 10.7326/0003-4819-149-9-200811040-00247. Epub 2008 Oct 7. Ann Intern Med. 2008. PMID: 18840787 No abstract available.
-
Perspectives: should older patients be screened for colorectal cancer?Dig Dis Sci. 2013 Dec;58(12):3643-5. doi: 10.1007/s10620-013-2836-1. Dig Dis Sci. 2013. PMID: 24129641 No abstract available.
Summary for patients in
-
Summaries for patients. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation.Ann Intern Med. 2008 Nov 4;149(9):I-44. doi: 10.7326/0003-4819-149-9-200811040-00246. Epub 2008 Oct 6. Ann Intern Med. 2008. PMID: 18838719 No abstract available.
Similar articles
-
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2009 Nov 17;151(10):716-26, W-236. doi: 10.7326/0003-4819-151-10-200911170-00008. Ann Intern Med. 2009. PMID: 19920272
-
Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.Ann Intern Med. 2008 Nov 4;149(9):638-58. doi: 10.7326/0003-4819-149-9-200811040-00245. Epub 2008 Oct 6. Ann Intern Med. 2008. PMID: 18838718 Review.
-
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.JAMA. 2016 Jun 21;315(23):2564-2575. doi: 10.1001/jama.2016.5989. JAMA. 2016. PMID: 27304597
-
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.JAMA. 2021 May 18;325(19):1965-1977. doi: 10.1001/jama.2021.6238. JAMA. 2021. PMID: 34003218
-
Screening for Colorectal Cancer: An Updated Systematic Review [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Oct. Report No.: 08-05-05124-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Oct. Report No.: 08-05-05124-EF-1. PMID: 20722162 Free Books & Documents. Review.
Cited by
-
Gastroenterology Specialist Supply and Early-Onset Colorectal Cancer Incidence and Mortality in the U.S., 2014-2018.Gastro Hep Adv. 2023 Apr 15;2(6):810-817. doi: 10.1016/j.gastha.2023.04.001. eCollection 2023. Gastro Hep Adv. 2023. PMID: 39130125 Free PMC article.
-
Genetic susceptibility association between viral infection and colorectal cancer risk: a two-sample Mendelian randomization analysis.Infect Agent Cancer. 2024 Aug 10;19(1):37. doi: 10.1186/s13027-024-00602-6. Infect Agent Cancer. 2024. PMID: 39123209 Free PMC article.
-
Synthesis, Characterization, and In-Vitro Evaluation of Silibinin-loaded PEGylated Niosomal Nanoparticles: Potential Anti-Cancer Effects on SW480 Colon Cancer Cells.Asian Pac J Cancer Prev. 2024 Jul 1;25(7):2539-2550. doi: 10.31557/APJCP.2024.25.7.2539. Asian Pac J Cancer Prev. 2024. PMID: 39068589 Free PMC article.
-
Unveiling Colorectal Cancer Biomarkers: Harnessing Biosensor Technology for Volatile Organic Compound Detection.Sensors (Basel). 2024 Jul 20;24(14):4712. doi: 10.3390/s24144712. Sensors (Basel). 2024. PMID: 39066110 Free PMC article. Review.
-
Differences in colorectal cancer awareness between screening eligible vs. ineligible Palestinians: a national cross-sectional study.Eur J Public Health. 2024 Oct 1;34(5):872-878. doi: 10.1093/eurpub/ckae083. Eur J Public Health. 2024. PMID: 38745392 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical